Subjective visual skin assessments lead to diagnostic errors and inconsistent treatment efficacy. Precise measurement of internal melanin and barrier markers enables objective clinical validation of dermatological interventions.
Subsurface biological markers and specific cell-type signatures are difficult to isolate or quantify without destructive sampling. Non-invasive identification of these internal states allows for longitudinal monitoring and diagnostic accuracy.